Literature DB >> 14596936

PKCdelta inhibits PKCalpha-mediated activation of phospholipase D1 in a manner independent of its protein kinase activity.

Masahiro Oka1, Taro Okada, Shun-ichi Nakamura, Motoi Ohba, Toshio Kuroki, Ushio Kikkawa, Hiroshi Nagai, Masamitsu Ichihashi, Chikako Nishigori.   

Abstract

The regulation of phospholipase D1 (PLD1) by protein kinase C (PKC) isoforms was analyzed in human melanoma cell lines. 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced PLD1 activation was suppressed by the introduction of PKCdelta as well as its kinase-negative mutant in MeWo cells, which contain PKCalpha but lack PKCbeta. PLD activity was not affected by PKCdelta in G361 cells, which have PKCbeta but are deficient in PKCalpha. In MeWo cells introduced by PKCalpha and PLD1, the association of these proteins was observed, which was enhanced by the TPA treatment. In cells overexpressing PKCdelta in addition to PKCalpha and PLD1, TPA treatment increased the association of PKCdelta and PLD1, while it attenuated the association of PKCalpha and PLD1. These results indicate that PKCdelta inhibits TPA-induced PLD1 activation mediated by PKCalpha through the association with PLD1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596936     DOI: 10.1016/s0014-5793(03)01158-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  PLD1 rather than PLD2 regulates phorbol-ester-, adhesion-dependent and Fc{gamma}-receptor-stimulated ROS production in neutrophils.

Authors:  Laura J Norton; Qifeng Zhang; Khalid M Saqib; Heinrich Schrewe; Karol Macura; Karen E Anderson; Craig W Lindsley; H Alex Brown; Simon A Rudge; Michael J O Wakelam
Journal:  J Cell Sci       Date:  2011-05-24       Impact factor: 5.285

2.  Protein kinase Cδ differentially regulates cAMP-dependent translocation of NTCP and MRP2 to the plasma membrane.

Authors:  Se Won Park; Christopher M Schonhoff; Cynthia R L Webster; M Sawkat Anwer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-28       Impact factor: 4.052

3.  Altered phospholipid transfer protein gene expression and serum lipid profile by topotecan.

Authors:  Rudel A Saunders; Kazuyuki Fujii; Leah Alabanza; Roald Ravatn; Tsunekazu Kita; Kazuya Kudoh; Masahiro Oka; Khew-Voon Chin
Journal:  Biochem Pharmacol       Date:  2010-04-21       Impact factor: 5.858

4.  12-O-tetradecanoylphorbol-13-acetate inhibits melanoma growth by inactivation of STAT3 through protein kinase C-activated tyrosine phosphatase(s).

Authors:  Masahiro Oka; Naoko Sumita; Masanobu Sakaguchi; Tetsushi Iwasaki; Toshinori Bito; Toshiro Kageshita; Ken-ichi Sato; Yasuo Fukami; Chikako Nishigori
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

Review 5.  Potential Role of Protein Kinase C in the Pathophysiology of Diabetes-Associated Atherosclerosis.

Authors:  Chih-Feng Lien; Sy-Jou Chen; Min-Chien Tsai; Chin-Sheng Lin
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.